Radiofrequency catheter ablation-induced gastroparesis successfully treated with administration of mosapride citrate: two case reports

Ogasawara, Nagahisa; Yamaguchi, Yoshiharu; Takahama, Takuya; Adachi, Kazunori; Suzuki, Manami; Izawa, Shinya; Ebi, Masahide; Funaki, Yasushi; Sasaki, Makoto; Kasugai, Kunio

doi:10.1007/s12328-019-01038-x

Cited by 3 publications

(3 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…As the only drug approved by Food and Drug Administration (FDA) for gastroparesis, metoclopramide can effectively alleviate PGS-related nausea, vomiting and other symptoms of the digestive system 61. 5-HT4 agonists such as cisapride are frequently and early adopted in PGS, and mosapride has also been used in gastroparesis 62–65. Prucalopride is a recently discovered effective drug that accelerates gastric emptying without cardiac side effects and has been initially reported to relieve symptoms in patients with idiopathic gastroparesis or diabetic gastroparesis,66 but high-quality studies in PGS are lacking.…”

Section: Discussionmentioning

confidence: 99%

“…61 5-HT4 agonists such as cisapride are frequently and early adopted in PGS, and mosapride has also been used in gastroparesis. [62][63][64][65] Prucalopride is a recently discovered effective drug that accelerates gastric emptying without cardiac side effects and has been initially reported to relieve symptoms in patients with idiopathic gastroparesis or diabetic gastroparesis, 66 but high-quality studies in PGS are lacking. Macrolide antibiotics such as erythromycin are agonists of GAS receptors, which induce GAS secretion in the proximal part of the digestive tract and accelerate gastric emptying.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Invasive acupuncture for gastroparesis after thoracic or abdominal surgery: a systematic review and meta-analysis

Fan

Qiu

et al. 2023

BMJ Open

View full text Add to dashboard Cite

ObjectivesThis meta-analysis aimed to systematically evaluate the efficacy of acupuncture in treating postsurgical gastroparesis syndrome (PGS) after thoracic or abdominal surgery.DesignSystematic review and meta-analysis.Data sourcesTwelve databases (PubMed, Embase, Cochrane Library Cochrane Central Register of Controlled Trials (CENTRAL), Medline (Ovid) (from 1946), Web of Science, EBSCO, Scopus, Open Grey, China National Knowledge Infrastructure (CNKI), Wanfang Database, Chinese Scientific Journals Database (VIP) and China Biology Medicine disc (CBM)) and three registration websites (WHO International Clinical Trials Registry Platform (ICTRP), ClinicalTrials.gov, and Chinese Clinical Trial Registry (ChiCTR)) were searched from the inception to September 2022, and citations of the included literature were screened.Eligibility criteriaAll randomised controlled trials addressing invasive acupuncture for PGS.Data extraction and synthesisKey information on the included studies was extracted by two reviewers independently. Risk ratio (RR) with 95% CI was used for categorical data, and mean difference with 95% CI for continuous data. The quality of evidence was assessed using Grading of Recommendations Assessment, Development and Evaluation. Outcomes were conducted with trial sequential analysis (TSA).ResultsFifteen studies with 759 patients met the inclusion criteria. Subgroup analyses revealed that compared with the drug group, the drug and acupuncture group had a greater positive effect on the total effective rate (TER) (nine trials, n=427; RR=1.20; 95% CI 1.08 to 1.32; P-heterogeneity=0.20, I2=28%, p=0.0004) and the recovery rate (RCR) (six trials, n = 294; RR = 1.61; 95% CI 1.30 to 1.98; P-heterogeneity=0.29, I2=19%, p<0.0001) of PGS after abdominal surgery. However, acupuncture showed no significant advantages in terms of the TER after thoracic surgery (one trial, p=0.13) or thoracic/abdominal surgery-related PGS (two trials, n = 115; RR=1.18; 95% CI 0.89 to 1.57; P-heterogeneity=0.08, I2=67%, p=0.24) and the RCR after thoracic/abdominal surgery (two trials, n=115; RR=1.40; 95% CI 0.97 to 2.01; P-heterogeneity=0.96, I2=0%, p=0.07). The quality of evidence for TER and RCR was moderate certainty. Only one study reported an acupuncture-related adverse event, in the form of mild local subcutaneous haemorrhage and pain that recovered spontaneously. TSA indicated that outcomes reached a necessary effect size except for clinical symptom score.ConclusionBased on subgroup analysis, compared with the drug treatment, acupuncture combined drug has significant advantages in the treatment of PGS associated with abdominal surgery, but not with thoracic surgery.PROSPERO registration numberCRD42022299189.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Invasive acupuncture for gastroparesis after thoracic or abdominal surgery: a systematic review and meta-analysis

Fan

Qiu

et al. 2023

BMJ Open

View full text Add to dashboard Cite

show abstract

“…The iatrogenic theory states that history of Invasive procedures like surgery [28] or embolization [31], [32] , or systemic vasopressin infusion are precursors to Acute gastric dilatation. A history of Radiofrequency ablation for ventricular tachycardia is reported to cause Acute gastric dilatation the most plausible explanation for the latter being the RFA induced interference of the vagus nerve [20] . Likewise Infective causes like regional hepatic Porto thrombophlebitis also predispose to acute gastric dilatation [13], [39] .…”

Section: Discussionmentioning

confidence: 99%

Acute Gastric Dilatation: “A Gluttony or a Crises in a Pandemic” An Update with review of Current literature

2022

ajsrr

View full text Add to dashboard Cite

Gastrectasia, Ectasia, or Acute gastric dilatation is a surgical emergency. Historically it was associated with binge eating, branded as gluttony, wolf eating and today goes by a refined name BED or binge eating disorder. Myriad in spectrum presentation the triggers continue to be the same a history of psychiatric disorders like anorexia nervosa, bulimia, and psychogenic polyphagia (1), (2) or following surgical procedure like fundoplication, pyloric stenosis. A masquerader in abdomen emergencies with abdominal pain and vomiting in the initial stages to shock & multiorgan collapse in later presentation. If not picked early the consequences disastrous. The mortality and morbidity from gastric dilatation is reported at 80% to 100% (1), ( 2), ( 21).

show abstract

Gastroparesis Secondary to Pulmonary Vein Cryoablation: A Factor to Consider

Vílchez¹,

Colomo²,

Maldonado³

2020

Rev Esp Enferm Dig

View full text Add to dashboard Cite

Radiofrequency catheter ablation-induced gastroparesis successfully treated with administration of mosapride citrate: two case reports

Cited by 3 publications

References 13 publications

Invasive acupuncture for gastroparesis after thoracic or abdominal surgery: a systematic review and meta-analysis

Invasive acupuncture for gastroparesis after thoracic or abdominal surgery: a systematic review and meta-analysis

Acute Gastric Dilatation: “A Gluttony or a Crises in a Pandemic” An Update with review of Current literature

Gastroparesis Secondary to Pulmonary Vein Cryoablation: A Factor to Consider

Contact Info

Product

Resources

About